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Background: Sagittal abdominal diameter (SAD) is a novel anthropometric measure hypothesized to be a
surrogate measure of visceral abdominal obesity in adults. This study aims to determine whether SAD is superior to
other anthropometric measures such as body mass index (BMI) and waist to hip ratio (WHR) in terms of association
to cardiometabolic risk and circulating adipocytokine concentrations in a cohort of Saudi children and adolescents.
Methods: A total of 948 (495 boys and 453 girls) apparently healthy children with varying BMI, aged 10–17 years,
were included in this cross sectional study. Fasting glucose, lipid profile, leptin, adiponectin, resistin, insulin,
TNF-α and aPAI-1 were measured in serum and HOMA-IR was calculated. MetS components were defined
according to the International Diabetes Federation (IDF) criteria.
Results: BMI was superior to SAD as well as WHR, and had the highest number of significant associations to MetS
components and adipocytokines even after adjustment for age and gender, including blood pressure, lipids,
glucose and leptin.
Conclusion: In conclusion, while SAD is significantly associated with components of MetS among children and
adolescents, it is not superior to BMI. The use of SAD therefore may not be practical for use in the pediatric clinical
setting. Follow-up studies are needed to determine whether SAD has clinical significance in terms of harder
outcomes such as predicting diabetes mellitus or cardiovascular diseases.
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Obesity confers increased risk for cardiovascular diseases
as a result of accumulation of visceral fat, which alters
intermediary metabolism and insulin sensitivity of per-
ipheral tissues [1-5]. Conventionally, waist circumference
is used in both clinical practice and biomedical research
to measure abdominal obesity and to screen for the
presence of the metabolic syndrome (MetS). Other an-
thropometric indices, such as body mass index (BMI), as* Correspondence: omrattas@ksu.edu.sa
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reproduction in any medium, provided the orwell as the waist-hip ratio (WHR), are two of the most
commonly used non-invasive biomarkers of obesity.
While BMI remains the most popular obesity measure,
its main disadvantage and limitation over waist circum-
ference and WHR is that it does not take into account
body fat distribution, a major predisposing factor to
metabolic abnormalities. However, a novel anthropomet-
ric index that can rival WHR and waist circumference in
clinical risk assessment is the sagittal abdominal diam-
eter (SAD), considered a reliable surrogate measure of
visceral abdominal fat, the fat tissue type that is signifi-
cantly associated with cardiometabolic risk variables
such as obesity, dyslipidemia and hypertension [6-8],
measured non-invasively by a simple caliper [9].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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perior correlate of MetS criteria and insulin resistance
than waist circumference, there has been little incorpor-
ation of this measure into routine clinical practice [10-12].
Furthermore, SAD was recently suggested to be superior
to waist circumference in predicting dyslipidemia and
hyperglycemia, at least in overweight adults [13]. The
latter, measured at the level of the umbilicus, is modestly
associated with coronary heart disease and visceral fat in
males, at least in adults [4,14]. To date, very few studies
have correlated SAD to other metabolic abnormalities,
especially in children. Furthermore, very few studies
have examined whether SAD in children and adolescents
is superior to other anthropometric parameters in pre-
dicting cardiometabolic risk factors, particularly in this
peninsula where increased prevalence of MetS and
chronic diseases have been observed in both children
and adults [15-17]. Thus, the present study aims to de-
termine the superior marker of obesity through compari-
sons of SAD, BMI, WHR in terms of association
strength with metabolic risk factors and levels of circu-
lating adipocytokines in a cohort of Saudi children.
Methods
A total of 948 (495 male and 453 female) Saudi children
aged between 10 and 17 years, were randomly selected
from the existing database of the Biomarkers Screening
in Riyadh Program (RIYADH Cohort), a capital-wide
study composed of randomly selected individuals from
different Primary Health Care Centers (PHCCs) in Riy-
adh, KSA. Ethical approval was granted by the Ethics
Committee of the College of Science Research Center,
King Saud University (KSU), Riyadh, KSA. Written con-
sent was obtained after study orientation. The study was
carried out at the Biomarkers Research Program, KSU,
Riyadh, KSA. A questionnaire focusing on demographic
information and past medical history was given to all
participating subjects. Children with acute co-
morbidities that needed immediate medical attention
were excluded from the study. MetS components were
defined according to International Diabetes Federation
(IDF) criteria [18].
Anthropometry
Anthropometry included height (to the nearest 0.5 cm)
and weight (to the nearest 0.1 kg), as well as waist and
hip circumferences utilizing a standardized measuring
tape in cm. The Holtain Khan abdominal caliper by Hol-
tain Ltd (Crymych, UK) was used to measure SAD as
previously described [19]. In brief, each subject was
examined supine on a firm examination table. Using
sliding calipers with parallel blades a direct reading can
be made between its lower arm (touching the subject's
back) and its sliding upper arm (touching the front ofthe subjects abdomen). BMI was calculated as kg/m2
and systolic and diastolic blood pressure measurements
were obtained. The definition of BMI-based obesity
employed is gender and age specific as proposed by Cole
and colleagues [20], which provides cut off points for
body mass index in childhood that was based on inter-
national survey and linked to the widely accepted adult
cut-off points for overweight and obesity (BMI of 25 and
30 kg/m2, respectively).
Blood chemistry
Participating subjects were requested to return to their
respective PHCCs after an overnight fast for anthropom-
etry and blood withdrawal. Blood was transferred imme-
diately to a non-heparinized tube for centrifugation.
Serum was then transferred to a pre-labeled plain tube,
stored in ice, and delivered to the Biomarkers Research
Program in KSU on the same day. Fasting serum sam-
ples were stored in a −20 °C freezer until analysis. Fast-
ing glucose (FG) and lipid profile were measured using a
chemical analyzer (Konelab, Vantaa, Finland). Serum lep-
tin, adiponectin, resistin, insulin, TNF-α and aPAI-1
were measured using a Luminex instrument (Linco Re-
search Inc., USA). The intra- and inter-assay variations
were 1.4-7.9% and < 21%, respectively for the above men-
tioned parameters measured using Luminex multiplex
assay. Minimum detectable concentrations (MDC) were:
leptin, 85.4 pg/ml; adiponectin, 145.4 pg/ml; resistin,
6.7 pg/ml; insulin, 50.9 pg/ml; TNF-α, 0.14 pg/ml, and
aPAI-1, 1.3 pg/ml. hsC-reactive protein was determined
using enzyme-linked immunosorbent assays (ELISA)
(Immunodiagnoztik AG, Germany) with an intra- and
inter-assay variations of 5.5-6.0% and 11.6-13.8%, re-
spectively. Serum angiotensin II was measured using
human angiotensin II EIA kit (Phoenix pharmaceuti-
cals, Belmont, CA, USA), (MDC 13 pg/ml; linear range
13–240 pg/ml) with intra- and inter-assay variations of
5.0-10.0% and < 15.0%, respectively. Homeostasis model
assessment of insulin resistance (HOMA-IR) was calcu-
lated as fasting insulin (μU/mL) times fasting glucose
(mmol/L)/22.5.
Statistical analyses
Data were analyzed using the Statistical Package for the
Social Sciences (SPSS for Windows, version 11.5). Data
were expressed as mean plus/minus standard error.
Group comparisons were done using one way Analysis
of Co-variance (ANCOVA), with age and gender as cov-
ariates, and Bonferroni analysis post-hoc. Frequencies
were expressed as percent (%). Partial (adjusted for age
and gender) and bivariate (raw, unadjusted) correlation
coefficients were determined and regression analysis
was done to determine relations between variables of
interest. Area under the curve (AUC) was done to
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than 0.05 were accepted to indicate statistically signifi-
cant differences.Results
Table 1 shows the basic characteristics of subjects. The
over-all prevalence of childhood obesity in this cohort
was 11.7%. Figure 1 shows the positive linear trend be-
tween SAD and age in both boys and girls as well as the
mean SAD across ages. Mean SAD for girls reach a
growth peak from ages 12–14, where the difference be-
tween boys is at its maximum, and starts to plateau at
15 years. Mean SAD for boys on the other hand starts to
increase at 13 years of age and continues to rise mod-
estly until 16 years (Figure 1).Table 1 General characteristics of the study population
Parameters
N 948
Age (years) 13.7 ± 2.2
Obese (%) 11.7
Overweight (%) 16.7
Gender (Male/Female) (%) 52.2/47.8
Body Mass Index (kg/m2) 22.1 ± 6.3
BMI z-score 0.001*10-13 ± 1.0
Waist circumference (cm) 77.1 ± 20.5
Hip circumference (cm) 86.4 ± 19.8
Waist-Hip Ratio 0.91 ± 0.33
Sagittal Abdominal Diameter (cm) 17.4 ± 5.4
Sagittal Abdominal Diameter z-score 0.18 ± 0.67
Systolic Blood Pressure (mmHg) 106.4 ± 10.6
Diastolic Blood Pressure (mmHg) 69.5 ± 7.8
Glucose (mmol/l) 5.1 ± 1.3
Insulin (ng/ml) 11.2 ± 1.2
HOMA-IR 2.6 ± 0.28
Triglycerides (mmol/l) 1.1 ± 0.60
Total Cholesterol (mmol/l) 4.2 ± 0.85
LDL-Cholesterol (mmol/l) 2.7 ± 0.76
HDL-Cholesterol (mmol/l) 1.1 ± 0.35
Leptin (ng/ml) 15.7 ± 2.8
Adiponectin (μg/ml) 20.4 ± 1.4
Resistin (ng/ml) 18.6 ± 1.7
ANG II (ng/ml) 0.67 ± 0.05
aPAI-1 (ng/ml) 19.8 ± 2.4
C-Reactive Protein (μg/ml) 0.83 (2.8)
TNF-α (pg/ml) 8.6 ± 1.0
Note: Data represented by Mean± Standard Error; CRP in median and
inter-quartile range.Bivariate and partial correlations between anthropo-
metric indices and components of the metabolic syn-
drome, as well as inflammatory markers and
adipocytokines are shown in Table 2. Bivariate associa-
tions of SAD showed significant associations to 12 out
of 16 parameters examined; however, only blood pres-
sure, triglycerides, HDL-cholesterol, leptin, resistin and
aPAI-1 remained significant after adjusting for gender
and age. BMI z-score on the other hand, had the highest
number of significant associations, and retained blood
pressure, lipids, glucose, and leptin after adjustment for
age and gender. Finally, for WHR, only lipids (triglycer-
ides, LDL- and total cholesterol), ANG II, as well as
HOMA-IR remained significant after adjustment.
The area under the curve (AUCs) of various indices
and metabolic risk components are summarized in
Table 3. BMI z-score showed significance in all para-
meters measured with the exception of systolic blood
pressure. SAD was a significant predictor of most other
parameters, with the exception of systolic blood pressure
and triglycerides. Lastly, waist-hip ratio was significant
in glucose, 2 or more components of MetS and MetS
itself.
Discussion
The main finding of the present cross-sectional study is
that BMI was superior to both SAD and WHR in terms
of significant associations to cardiometabolic parameters
in children. SAD was no better than BMI, despite signifi-
cant correlations with MetS components, insulin sensi-
tivity indices and adipocytokine concentrations. Earlier
studies done among children of European and Turkish
descent showed that BMI was a better predictor of
WHR and skin folds, respectively, with SAD values
reported only as a correlate to BMI among European
children [21,22].
Our findings however, differ from other ethnic groups,
as waist circumference is more powerful in assessing
metabolic disorders over other anthropometric values
including SAD among Far Eastern children [23].
Our findings show that BMI is the best predictor of
cardiometabolic risk factors as compared to SAD and
WHR in children. With SAD however, some associations
with cardiometabolic parameters remained significant
even after adjustment for gender and age, notably blood
pressure, triglycerides, and HDL-cholesterol. SAD also
had more significant associations than BMI with regards
to the adipocytokines suggesting that SAD may have a
different predictive value independent of cardiometa-
bolic risk factors. With the exception of HOMA-IR,
these associations were not elicited with WHR. Further-
more, in terms of identifying adult patients with MetS,
SAD, in the absence of imaging techniques, has a sensi-
tivity of 91% and specificity of 80% in patients at risk for
Figure 1 Linear trend between sagittal abdominal diameter in varying age groups in both boys and girls.
Table 2 Bivariate (Unadjusted) and partial (Controlled for Gender and Age) correlations of BMI, WHR and SAD to
anthropometric and metabolic parameters
PARAMETERS BMI z-score WHR SAD z-score
Bivariate Partial Bivariate Partial Bivariate Partial
Systolic Blood Pressure (mmHg) 0.40 ** 0.19 ** 0.11 - 0.03 0.32 ** 0.20 **
Diastolic Blood Pressure (mmHg) 0.29 ** 0.18 ** - 0.01 - 0.03 0.25 ** 0.16 **
Glucose (mmol/l) 0.19 ** 0.18 ** 0.07 * 0.06 0.09 ** 0.02
Insulin (IU/ml) 0.52 ** - 0.01 0.17 * 0.10 0.38 ** - 0.10
HOMA-IR 0.52 ** - 0.01 0.21 ** 0.12 * 0.36 ** - 0.10
Triglycerides (mmol/l) 0.30 ** 0.21 ** 0.11 * 0.23 ** 0.17 ** 0.08 *
Total Cholesterol (mmol/l) 0.13 ** 0.14 ** - 0.02 - 0.11* 0.08 * 0.02
LDL-Cholesterol (mmol/l) 0.17 ** 0.17 ** - 0.04 - 0.24 ** 0.11 0.06
HDL-Cholesterol (mmol/l) - 0.25 ** - 0.19 ** - 0.04 0.09 - 0.20 ** - 0.14 **
Leptin (ng/ml) 0.49 ** 0.34 ** 0.04 0.01 0.35 ** 0.22 **
Adiponectin (μg/ml) - 0.25 ** - 0.14 - 0.14 0.00 - 0.20 ** - 0.16
Resistin (ng/ml) 0.18 ** 0.12 - 0.11 ** - 0.08 0.18 ** 0.07 *
ANG II (ng/ml) 0.04 - 0.01 0.07 0.15 * - 0.03 0.02
aPAI-1 (ng/ml) 0.13 ** 0.14 0.02 - 0.00 0.10 ** 0.10 **
C-Reactive Protein (μg/ml) 0.04 0.05 0.06 - 0.06 0.02 0.12
TNF-α (pg/ml) −0.03 −0.50 −0.04 −0.42 −0.02 −0.31
Note: Data presented as coefficients (R); * denotes p-value < 0.05 level; ** denotes p-value < 0.01 level.
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Systolic Blood Pressure BMI z-score 0.526 ± 0.040 0.926 (0.447, 0.605)
WHR 0.513 ± 0.001 0.094 (0.005, 0.031)
SAD z-score 0.539 ± 0.048 0.893 (0.445, 0.633)
Triglycerides BMI z-score 0.721 ± 0.065 0.010 (0.594, 0.848)
WHR 0.662 ± 0.069 0.060 (0.527,0.798)
SAD z-score 0.634 ± 0.080 0.119 (0.477, 0.792)
HDL-Cholesterol BMI z-score 0.623 ± 0.019 <0.001 (0.583, 0.660)
WHR 0.535 ± 0.020 0.070 (0.497, 0.574)
SAD z-score 0.599 ± 0.019 <0.001 (0.561, 0.636)
Glucose BMI z-score 0.615 ± 0.024 <0.001 (0.567, 0.662)
WHR 0.563 ± 0.025 0.012 (0.515, 0.612)
SAD z-score 0.554 ± 0.026 0.031 (0.504, 0.604)
2 or more IDF MetS
Components
BMI z-score 0.777 ± 0.016 <0.001 (0.747, 0.808)
WHR 0.641 ± 0.019 <0.001 (0.605, 0.678)
SAD z-score 0.678 ± 0.019 <0.001 (0.641, 0.714)
IDF MetS BMI z-score 0.776 ± 0.025 <0.001 (0.727, 0.825)
WHR 0.632 ± 0.025 <0.001 (0.582, 0.681)
SAD z-score 0.693 ± 0.029 <0.001 (0.636, 0.750)
Note: Significant at p < 0.05.
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assessing cardiovascular risk among the severely obese
[25]. It is noted however that the predictive utility of
SAD among normal adults, and in this case, children,
will be clearly less as compared to those who harbor
known CVD risk factors such as obesity. In the present
study, the significant influence of SAD on the expression
of numerous adipocytokines makes it a better measure
than WHR, but not as good as BMI, in assessing cardio-
metabolic risk profile in children. This is because when
waist or hip circumference is measured in a standing
person with an increased volume of intra-abdominal adi-
pose tissue, all fat tissue is pulled towards gravity, and
may therefore not be that accurate in assessing intra-
abdominal fat especially among children who are very
obese. When the same person lies supine the fat mass
shifts cranially, causing anterior projection of the abdo-
men (abdominal height) which is measured by the SAD
[19]. It is the antero-posterior fat that seems to be im-
portant for the prediction of the MetS. The persistence
of significant associations of lipids and selected adipocy-
tokines with SAD agrees with the findings of several
cross-sectional observations that SAD is the surrogate
marker for visceral fat as compared to waist circumfer-
ence [26,27].
The authors acknowledge some limitations. The cross-
sectional nature of the study limits our findings toobservations and only prospective longitudinal studies
can confirm whether the persistence of these associa-
tions translate into increased odds of developing chronic
diseases. Pubertal status was also not assessed and this
could have affected the results, since BMI, waist circum-
ference, SAD and MetS itself can also be influenced by
the developmental trajectories and hormonal changes
occurring during adolescence, and excess adiposity dur-
ing childhood could advance puberty in girls and delay
onset in boys [28]. Finally, the results cannot be general-
ized, as it may differ if applied to children of other
ethnicities.
Conclusion
In conclusion, while SAD is significantly associated with
several components of MetS, including adipcytokines in
Arab children and adolescents, it is not superior to BMI
in terms of association strength. The use of SAD, there-
fore, may not be clinically practical for routine use as
compared to BMI, at least among children, but is more
useful clinically when compared to waist-hip ratio. Pro-
spective longitudinal studies are suggested to compare
its causal association with harder endpoints such as early
onset diabetes and cardiovascular disease.
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